In a report released today, Edward White from H.C.
The post H.C. Wainwright Keeps a Buy Rating on TG Therapeutics (TGTX) appeared first on Smarter Analyst.
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on TG Therapeutics (TGTX), with a price target of $89.00. ...

https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-keeps-a-buy-rating-on-tg-therapeutics-tgtx-2/

#SmarterAnalyst